Anticoagulation

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: The RIGHT Study

Yan Yan, Gilles Montalescot,

Watch time: 5m 21s
ESC 23: The ONCO DVT Study

Yugo Yamashita,

Watch time: 4m 8s
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s

Yugo Yamashita,

Radcliffe & CardioNerds @AHA22: The PREVENT-HD Randomized Clinical Trial

Kahtan Fadah, Gregory Piazza,

Watch time: 15m 37s

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s

Sonika Malik , Anju Bhardwaj , Matthew Eisen , et al

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Alex Spyropoulos, Gary E Raskob,

Watch time: 1h 2m 6s

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s

Karthiek R Narala , Thomas A LaLonde , Sohail Hassan , et al

Yugo Yamashita,

Donald E Cutlip ,

Johny Nicolas , Usman Baber , Roxana Mehran ,

Payam Pournazari , Su Min Chang , Stephen H Little , et al

Robert Barcelona ,

Read time: 23m

Media

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s

Yugo Yamashita,

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s

Watch time: 3h 52m 31s
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 28m 6s

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

Media

CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s

Yugo Yamashita,

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
ESC 23: The ONCO DVT Study

Yugo Yamashita,

Watch time: 4m 8s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
ESC 23: The RIGHT Study

Yan Yan, Gilles Montalescot,

Watch time: 5m 21s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s

Articles

Prosthetic Aortic Valve Thrombosis

Payam Pournazari

,

Su Min Chang

,

Stephen H Little

,

Sachin Goel

,

Nadeen N Faza

,

Published:

08 July 2022

Citation:

US Cardiology Review 2022;16:e17.

DOI:

https://doi.org/10.15420/usc.2021.19
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2376
  • Downloads: Downloads 153
  • Citations: 1

Best Practices in Pharmacotherapy for Acute Coronary Syndromes

Robert Barcelona

,

Published:

01 July 2022

Citation:

US Cardiology Review 2022;16:e16.

DOI:

https://doi.org/10.15420/usc.2022.05
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2335
  • Downloads: Downloads 206
  • Read time: 23m

Dual Antiplatelet Regimens for TAVR and Cardiac CT Evaluation of Leaflets

Mirvat Alasnag

,

Waqar Ahmed

,

Ibrahim Al-Nasser

,

Khaled Al-Shaibi

,

Published:

10 February 2022

Citation:

US Cardiology Review 2022;16:e04.

DOI:

https://doi.org/10.15420/usc.2021.07
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 941
  • Downloads: Downloads 54
  • Read time: 15m

Type and Duration of Antithrombotic Treatment in Complex PCI

Despoina-Rafailia Benetou

,

Charalampos Varlamos

,

Christos Pappas

,

Fotios Kolokathis

,

Dimitrios Alexopoulos

,

Published:

13 October 2021

Citation:

US Cardiology Review 2021;15:e17.

DOI:

https://doi.org/10.15420/usc.2020.30
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1019
  • Downloads: Downloads 80
  • Read time: 18m